Published in

Elsevier, Nanomedicine: Nanotechnology, Biology and Medicine, 2(9), p. 159-173, 2013

DOI: 10.1016/j.nano.2012.06.001

Links

Tools

Export citation

Search in Google Scholar

Polymeric nanogels as vaccine delivery systems

Journal article published in 2013 by Sílvia A. Ferreira ORCID, Francisco M. Gama ORCID, Manuel Vilanova ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Polymeric nanogels find a relevant field of application in the formulation of a new generation of therapeutic and preventive vaccines, aiming at the fine-tuned modulation of the immune response. Intrinsic properties of polymeric nanogels, such as material chemistry, size and shape, surface charge, and hydrophobicity or hydrophilicity, may be determining factors in shaping the induced immune response. These materials can thus work as synthetic adjuvants, which can also be conjugated with immunostimulants. Polymeric nanogels protect vaccine antigens from degradation in vivo and, surface-conjugated with antibodies or specific ligands, could increase active targeting specificity. This review covers the recent published data concerning the modulation of innate and adaptive immune responses by engineered polymeric nanogels and their potential application as delivery systems in vaccination.